Health and Fitness Health and Fitness
Tue, August 14, 2012
[ Tue, Aug 14th 2012 ] - Market Wire
Lorus Therapeutics Announces Issuance of Patent i .. ancer Drug LOR-253 and Antimicrobial Drug LOR-220
[ Tue, Aug 14th 2012 ] - Market Wire
EntreMed Reports Second Quarter 2012 Financial Results
[ Tue, Aug 14th 2012 ] - Market Wire
Pharmacyclics Appoints Joshua T. Brumm Executive Vice President of Finance
Mon, August 13, 2012
[ Mon, Aug 13th 2012 ] - Market Wire
Graymark Healthcare and Foundation Healthcare Sign Definitive Purchase Agreement
[ Mon, Aug 13th 2012 ] - Market Wire
CytoSorbents Reports Corporate Update and Second Quarter 2012 Financial Results
[ Mon, Aug 13th 2012 ] - Market Wire
Isis Pharmaceuticals Announces Redemption Of 2 5/8% Convertible Subordinated Notes Due 2027
[ Mon, Aug 13th 2012 ] - Market Wire
Transcept Pharmaceuticals Reports Second Quarter 2012 Financial Results
[ Mon, Aug 13th 2012 ] - Market Wire
Transition Therapeutics to Present at the Canaccord Genuity Annual Growth Conference
[ Mon, Aug 13th 2012 ] - Market Wire
Skystar to File Second Quarter Fiscal Year 2012 on Tuesday, August 14, 2012
[ Mon, Aug 13th 2012 ] - Market Wire
Hangover Joe's The Hangover Recovery Shot Prepare .. , Now Available in Thousands of Stores Nationwide
[ Mon, Aug 13th 2012 ] - Market Wire
Critical Trade Alerts For Amgen, Western Digital, .. and Oasis Petroleum Released By InvestorsObserver
[ Mon, Aug 13th 2012 ] - Market Wire
Rosetta Genomics Receives 2012 North American Ent .. of the Year Award by Frost amp;; Sullivan
[ Mon, Aug 13th 2012 ] - Market Wire
GeoVax Reports 2012 Second Quarter Financial Results
[ Mon, Aug 13th 2012 ] - Market Wire
Icahn Responds To Forest Labs Board
[ Mon, Aug 13th 2012 ] - Market Wire
Varian Medical Systems Board of Directors Authori .. 8 Million Shares of Stock through Calendar Year 2
[ Mon, Aug 13th 2012 ] - Market Wire
HealthSouth Amends Senior Credit Facility
[ Mon, Aug 13th 2012 ] - Market Wire
NewBridge Pharmaceuticals Forms Partnership With .. Genomic Testing to Patients in Middle East, Afri
[ Mon, Aug 13th 2012 ] - Market Wire
Erich R. Reinhardt Appointed to Board of Directors of Varian Medical Systems
[ Mon, Aug 13th 2012 ] - Market Wire
Varian Medical Systems' CEO Timothy E. Guertin An .. 59; Board of Directors Names Dow R. Wilson as Suc
[ Mon, Aug 13th 2012 ] - Market Wire
USANA Health Sciences Supports Mexico National Soccer
[ Mon, Aug 13th 2012 ] - Market Wire
ImmuCell Announces Profitable Financial Results
[ Mon, Aug 13th 2012 ] - Market Wire
ProPhase Labs Reports Financial Results for the Three and Six Months Ended June 30, 2012
[ Mon, Aug 13th 2012 ] - Market Wire
ProMetic Reports Its Second Quarter 2012 Highlights and Financial Results
[ Mon, Aug 13th 2012 ] - Market Wire
Adherex Reports Recent Developments and Second Quarter June 30, 2012 Financial Results
[ Mon, Aug 13th 2012 ] - Market Wire
Implant Sciences Announces New Sales to Nigeria for Aviation Security
[ Mon, Aug 13th 2012 ] - Market Wire
Comprehensive Care Corporation Announces Profitable Six Month Financial Results
Fri, August 10, 2012
[ Fri, Aug 10th 2012 ] - Market Wire
Quidel Secures New $140 Million Credit Facility
[ Fri, Aug 10th 2012 ] - Market Wire
Cadence Pharmaceuticals To Present At The Wedbush .. ment Access Conference In New York City On August
[ Fri, Aug 10th 2012 ] - Market Wire
Insception and Lifebank Announce Agreement for Insception to Acquire Lifebank
[ Fri, Aug 10th 2012 ] - Market Wire
Trimel to Present at Canaccord Genuity 32nd Annual Growth Conference

Trimel to Present at Canaccord Genuity 32nd Annual Growth Conference


Published on 2012-08-10 07:15:49 - Market Wire
  Print publication without navigation


August 10, 2012 10:00 ET

Trimel to Present at Canaccord Genuity 32nd Annual Growth Conference

TORONTO, ONTARIO--(Marketwire - Aug. 10, 2012) - Trimel Pharmaceuticals Corporation (TSX:TRL) (the "Company" or "Trimel") today announced that it will participate in the Canaccord Genuity 32nd Annual Growth Conference at the InterContinental Hotel in Boston, Massachusetts. Mr Kenneth Howling, Chief Financial Officer, is scheduled to present an overview of the Company on August 14, 2012 at 11:00 am EDT. The presentation materials will also be available on the Trimel website at [ www.trimelpharmaceuticals.com ].

For further information regarding Trimel Pharmaceuticals Corporation, please contact Kenneth Howling, Chief Financial Officer at (416) 679-0536 or Trimel via email at [ ir@trimelpharmaceuticals.com ].

About Trimel

Trimel Pharmaceuticals Corporation (TSX:TRL) - Developing medications for Female Sexual Health and conditions related to Aging, and Well Being. Trimel is developing multiple product opportunities, including CompleoTRT™, a bio-adhesive intranasal Testosterone gel currently in Phase III clinical testing in the United States. CompleoTRT™ is under investigation for the treatment of male hypogonadism, a condition commonly referred to as "Low T". For more information, please visit [ www.trimelpharmaceuticals.com ].



Contributing Sources